Michael S. Ettinger Sells 12,240 Shares of Henry Schein, Inc. (NASDAQ:HSIC) Stock

by · The Cerbat Gem

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Henry Schein Price Performance

Shares of HSIC opened at $73.91 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.21 billion, a P/E ratio of 30.41, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87. The stock’s 50-day moving average price is $70.68 and its two-hundred day moving average price is $69.69. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.32 earnings per share. On average, equities analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Cromwell Holdings LLC lifted its holdings in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Covestor Ltd raised its stake in Henry Schein by 12.8% during the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares in the last quarter. Studio Investment Management LLC grew its holdings in shares of Henry Schein by 3.8% during the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after purchasing an additional 172 shares during the last quarter. Simplify Asset Management Inc. increased its holdings in shares of Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after buying an additional 175 shares in the last quarter. Finally, Sequoia Financial Advisors LLC increased its holdings in Henry Schein by 3.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after purchasing an additional 176 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on HSIC shares. JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, Robert W. Baird cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $78.89.

Check Out Our Latest Research Report on Henry Schein

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles